-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGA-1901 in Helicobacter pylori Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BGA-1901 in Helicobacter pylori Infections Drug Details:BGA-1901 is under development for treatment of Helicobacter pylori infections....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QLS-111 in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QLS-111 in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.QLS-111 in Ocular HypertensionDrug Details:QLS-111 is under development for the treatment of normal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-19 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-19 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IM-19 in Primary Mediastinal B-Cell Lymphoma Drug Details: IM-19 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tesevatinib Tosylate in Metastatic Brain Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tesevatinib Tosylate in Metastatic Brain Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tesevatinib Tosylate in Metastatic Brain TumorDrug Details: Tesevatinib tosylate (KD-019, XL647)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pepinemab in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pepinemab in Oral Cavity (Mouth) Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Pepinemab in Oral Cavity (Mouth) CancerDrug Details:Pepinemab (VX-15) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cefiderocol Sulfate Tosylate in Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cefiderocol Sulfate Tosylate in Sepsis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cefiderocol Sulfate Tosylate in Sepsis Drug Details: Cefiderocol sulfate tosylate (Fetroja,...
-
Company Profile
Yunnan Tin Co Ltd – Company Profile
Yunnan Tin Co Ltd (YTC) is a tin producing company. It carries out exploration, mining, smelting, and processing of tin and other non-ferrous metals. Key products offered by the company include tin ingot, special tin for float glass production, bearing alloy ingot, lead-based alloy, tin-lead wire solder, copper cathode, zinc and tin zinc alloy wire, lead-free solder wire, lead-free solder bar and casting solder bar. The company also offers products such as extruded solder bar, tin granule, tin ball, spherical...
Add to Basket -
Company Profile
Toppan Inc – Company Profile
Toppan Holdings Inc (Toppan), formerly Toppan Inc, offers products and services for information and communication, living and industry, and electronics segments. The company’s product portfolio includes magnetic cards, books and magazines, catalogs, photomasks, plastic molded products, and securities-related documents. It also offers flip chip ball grid array (FC-BGA) substrates, GL films (a transparent barrier film), wallpapers, decor materials, surface treatment films, color filters and photomasks for semiconductors. The company’s key technologies include surface treatment, microfabrication, information processing and material forming....
Add to Basket -
Company Profile
Shinko Electric Industries Co Ltd – Company Profile
Shinko Electric Industries Co Ltd (Shinko), a subsidiary of Fujitsu Ltd, manufactures and sells semiconductor packages and integrated circuit (IC) chips for different industries. Its products include IC package such as plastic-BGA substrates, tape BGAs, build-up substrates and lead frames. The company also offers components such as ceramic packages, glass-to-metal seals, heat spreaders and ceramic electrostatic chucks. It sells products in both domestic and international markets to computing and networking, mobile, industrial, IoT, semiconductor, electronics, and automobile manufacturers. The company...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BGA-1901
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BGA-1901 Drug Details BGA-1901 is under development for treatment of Helicobacter pylori infections. It...